Abstract |
Between 1970 and 1979, 140 patients aged between 19 and 84 years with endoscopically confirmed gastric ulcer (GU), were treated with Biogastrone in reducing doses for 6 months. They received a daily dose of 300 mg for one week, 150 mg for 5 weeks, 100 mg for 6 weeks and 50 mg for the remainder of the 6 months. All the patients were reviewed at 2, 4, 6, 8, 12, 16, 20, 32, and 38 weeks and thereafter every 3 months or earlier in the event of significant dyspepsia. The anticipated recurrence rate of GU of approximately 42% at 2 years (3) was nearly halved to 26.7% over a median follow-up of 36 months in 140 cases completing the full six months course of treatment. The incidence of side effects was as follows: (i) A weight gain of 3.5 kg or more was seen in 23% of the patients at 2 weeks; this effect was maintained through the 6 month period. (ii) Oedema was noted in 14% of the patients at 2 weeks but declined to a 2% incidence by the end of the study. (iii) Elevated diastolic blood pressure in 14--18% of patients below 60 years and 20--27% patients above 60 years of age was noted throughout the study period. A high proportion of patients (38%) receiving other therapy had hypertension prior to the trial period; Carbenoxolone treatment had little further effect on blood pressure in these patients. (iv) Hypokalaemia was noted in the early stages of treatment especially in those over 60 years (43%). The incidence declined with the reduction in dosage through the 6 month treatment period. All side effects were successfully treated by diuretics and potassium supplements.
|
Authors | P C Ganguli, S D Mohamed |
Journal | Scandinavian journal of gastroenterology. Supplement
(Scand J Gastroenterol Suppl)
Vol. 65
Pg. 63-71
( 1980)
ISSN: 0085-5928 [Print] England |
PMID | 6937941
(Publication Type: Journal Article)
|
Chemical References |
- Carbenoxolone
- Glycyrrhetinic Acid
|
Topics |
- Adult
- Aged
- Blood Pressure
(drug effects)
- Body Weight
(drug effects)
- Carbenoxolone
(administration & dosage, adverse effects, therapeutic use)
- Edema
(chemically induced)
- Female
- Glycyrrhetinic Acid
(analogs & derivatives)
- Humans
- Hypokalemia
(chemically induced)
- Male
- Middle Aged
- Recurrence
- Stomach Ulcer
(prevention & control)
|